Deerland Probiotics & Enzymes, a global supplier of science-backed solutions for microbiome health, has completed the integration of Denmark-based Bifodan A/S, which was acquired in 2019.
The two companies now operate as one global entity under the Deerland brand.
With this development, customers of Deerland and the former Bifodan now enjoy full access to an expanded portfolio of science-backed probiotic, prebiotic and enzyme technologies through branded ingredients, customised formulations and ready-to-market turnkey solutions in more than 40 countries around the world.
“We are excited to unleash the power of two organisations, now operating as one elite global solutions provider,” said Scott Ravech, CEO of Deerland.
“Together, we are one step closer to achieving our vision of all people of all cultures benefiting from our enzyme, probiotic and prebiotic health products and science-backed technologies.”
Deerland’s acquisition of Bifodan effectively enlarged its global footprint making the company’s value proposition stronger than ever.
In the months following the acquisition, the companies worked together to integrate the two organisations to better serve their existing and new customers.
Sales and marketing teams addressed how the combined company would collaborate with customers to develop innovative and proprietary solutions.
The global research and development teams ensured each product offering would be supported with sound clinical science, and manufacturing teams optimised production in the company’s four state-of-the-art TGA and cGMP certified facilities around the globe.
